高钾血症有多危险?
本文综述高钾血症与不良结局的临床数据,指出流行病学显示高钾血症与发病率和死亡率强相关,但传统认为心电图可可靠诊断及特定血钾水平即致心脏毒性的观点受到不典型表现病例的挑战。生理适应、结构性心脏病、用药及合并症程度可能影响毒性阈值,临床背景对结局的判定至少与高钾程度同等重要。
要点
- 高钾血症与不良结局强相关,但传统心电图诊断和特定阈值致毒性的观点受挑战。
- 临床背景(生理适应、心脏病、用药、合并症)影响毒性阈值,常被忽视。
- 高钾血症的临床背景对患者结局的判定至少与高钾程度同等重要。
核心结论
- 高钾血症的临床背景对患者结局的判定至少与高钾程度同等重要。
研究设计与样本
- 本文为综述,总结高钾血症与不良结局的临床数据并讨论治疗疗效如何取决于临床表现。
主要发现
- 流行病学数据显示高钾血症与发病率和死亡率强相关,但在某些人群和不同临床表现中关联似乎脱节。
- 不典型表现的病例报告挑战了传统认为心电图可可靠诊断高钾血症及特定血钾水平即致心脏毒性的观点。
- 生理适应、结构性心脏病、用药及合并症程度可能使某些高钾血症患者毒性阈值降低或升高。
临床怎么用
- 临床评估高钾血症时应结合生理适应、结构性心脏病、用药及合并症等背景,而非仅依赖血钾水平或心电图。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Hyperkalemia is a potentially life-threatening electrolyte disorder appreciated with greater frequency in patients with renal disease, heart failure, and with use of certain medications such as renin angiotensin aldosterone inhibitors. The traditional views that hyperkalemia can be reliably diagnosed by electrocardiogram and that particular levels of hyperkalemia confer cardiotoxic risk have been challenged by several reports of patients with atypic presentations. Epidemiologic data demonstrate strong associations of morbidity and mortality in patients with hyperkalemia but these associations appear disconnected in certain patient populations and in differing clinical presentations. Physiologic adaptation, structural cardiac disease, medication use, and degree of concurrent illness might predispose certain patients presenting with hyperkalemia to a lower or higher threshold for toxicity. These factors are often overlooked; yet data suggest that the clinical context in which hyperkalemia develops is at least as important as the degree of hyperkalemia is in determining patient outcome. This review summarizes the clinical data linking hyperkalemia with poor outcomes and discusses how the efficacy of certain treatments might depend on the clinical presentation.
引用
- Montford JR, Linas S. How Dangerous Is Hyperkalemia? J Am Soc Nephrol. 2017. PMID: 28778861. doi:10.1681/ASN.2016121344
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。